Legal Questions Swirl Around FDA's New Expedited Drug Program

(MedPage Today) — The effort by FDA Commissioner Marty Makary, MD, MPH, to drastically shorten the review of drugs favored by President Donald Trump’s administration is causing alarm across the agency, stoking worries that the plan may run afoul…

Source link : https://www.medpagetoday.com/publichealthpolicy/fdageneral/119467

Author :

Publish date : 2026-01-16 17:06:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

Legal Questions Swirl Around FDA’s New Expedited Drug Program

RAAC Hospitals to Miss 2030 Rebuild Deadline

Microplastics and Your Health: What to Know

Related Posts

Type 1 Diabetes Linked to Threefold Increase in Dementia Risk

When a Trip to the Hair Salon Ends in the Emergency Room

FDA OKs First Drug for Liver Disease-Related Pruritus

Alzheimer’s Gene Carriers With Higher Meat Intake Had Lower Dementia Risk

Australian Private Health Insurers Are Buying Up GP Clinics

AI Strategy Could Eliminate Radiologist Review of Low-Risk Mammograms

Type 1 Diabetes Linked to Threefold Increase in Dementia Risk

When a Trip to the Hair Salon Ends in the Emergency Room

FDA OKs First Drug for Liver Disease-Related Pruritus

Alzheimer’s Gene Carriers With Higher Meat Intake Had Lower Dementia Risk

Australian Private Health Insurers Are Buying Up GP Clinics

AI Strategy Could Eliminate Radiologist Review of Low-Risk Mammograms

Should Doctors Charge Patients for Prior Authorization?

Poll Shows What ACA Enrollees Are Cutting Back on to Afford Healthcare

Categories

Archives